More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
Google Cloud Next 2026 | Meet Abt in Las Vegas
Connect with Abt on secure AI, cloud modernization, and data tools built to help government act faster and serve people well.
2026 NEWMOA PFAS Conference
Abt brings PFAS data tools and decision support for agencies facing urgent questions on exposure, health, and environmental response.
Abt Names Sunnie McClain Vice President of Digital Solutions
Abt appoints Sunnie McClain as VP digital solutions to align digital capabilities with client needs and drive practical, mission-focused delivery.
Rural Communities Opioid Response Program (RCORP) Evaluation
Abt supports HRSA’s rural opioid response by evaluating RCORP grants, strengthening reporting quality, and guiding targeted support for communities.